BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33222286)

  • 1. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
    Russell-Goldman E; Hornick JL; Hanna J
    J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
    Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
    Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
    Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
    J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
    Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
    J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.
    Parra O; Kerr DA; Bridge JA; Loehrer AP; Linos K
    J Cutan Pathol; 2021 Jan; 48(1):95-101. PubMed ID: 32757412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
    Li P; Busam KJ
    J Cutan Pathol; 2024 Mar; 51(3):226-229. PubMed ID: 38088454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
    Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
    J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
    Christensen DJ; Tuluc M
    J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
    Kervarrec T; Frouin E; Collin C; Tallet A; Tallegas M; Pissaloux D; Tirode F; Guyétant S; Samimi M; Gaboriaud P; Touzé A; Schrama D; Houben R; Tabareau-Delalande F; Neuhart A; de la Fouchardière A; Osio A; Cavelier-Balloy B; Laurent-Roussel S; Sohier P; Cyprien T; Balme B; Belzung F; Jullie ML; Cribier B; Battistella M; Macagno N
    Histopathology; 2023 May; 82(6):885-898. PubMed ID: 36720791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma.
    Goto K; Ishikawa M; Hamada K; Muramatsu K; Naka M; Honma K; Sugino T
    Am J Dermatopathol; 2021 Nov; 43(11):781-787. PubMed ID: 33767067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
    Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
    Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
    Kervarrec T; Pissaloux D; Tirode F; de la Fouchardière A; Sohier P; Frouin E; Hamard A; Houben R; Schrama D; Barlier A; Cribier B; Battistella M; Macagno N
    Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor.
    Agaimy A; Stoehr R; Tögel L; Hartmann A; Cramer T
    Head Neck Pathol; 2021 Mar; 15(1):361-367. PubMed ID: 32504288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature.
    Hartsough EM; Moran J; Devins K; Wszolek M; Cornejo KM
    Am J Dermatopathol; 2023 Jan; 45(1):51-55. PubMed ID: 36484607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant poroma and porocarcinoma.
    Abarzúa Á; Álvarez-Véliz S; Moll-Manzur C
    An Bras Dermatol; 2017; 92(4):550-552. PubMed ID: 28954110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP1::MAML2 fusions in poromatosis: A report of two patients.
    Mitsui Y; Ogawa K; Goto K; Fujii T; Nakamura-Nishimura Y; Mashiba K; Asada H
    J Cutan Pathol; 2023 Aug; 50(8):695-701. PubMed ID: 36723803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of YAP1 C-terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement.
    Wang X; Liu LL; Li Q; Xia QY; Li R; Ye SB; Zhang RS; Fang R; Chen H; Wu N; Rao Q
    Histopathology; 2023 Nov; 83(5):798-809. PubMed ID: 37565303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma.
    Goto K; Takai T; Fukumoto T; Anan T; Kimura T; Ansai S; Oshitani Y; Murata Y; Sakuma T; Hirose T
    J Cutan Pathol; 2016 Mar; 43(3):219-26. PubMed ID: 26449497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.
    Bosic M; Kirchner M; Brasanac D; Leichsenring J; Lier A; Volckmar AL; Oliveira C; Buchhalter I; Stögbauer F; Zivkovic-Perisic S; Goeppert B; Schirmacher P; Penzel R; Endris V; Stenzinger A
    Pathology; 2018 Apr; 50(3):327-332. PubMed ID: 29269125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma.
    Zahn J; Chan MP; Wang G; Patel RM; Andea AA; Bresler SC; Harms PW
    J Cutan Pathol; 2019 Sep; 46(9):659-664. PubMed ID: 31012122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.